Clinical trials sponsored by Inge Marie Svane

Phase breakdown

Conditions studied

Recruiting trials led by Inge Marie Svane

• Melanoma Metastasized to the Brain and Steroids
  NCT03563729 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
  NCT07501117 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
  NCT06783270 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
  NCT06204991 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is Inge Marie Svane recruiting for?

Inge Marie Svane is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.